| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Medicine | 986 | 169 | 162 | 23 |
The journal covers a variety of subjects, including Internal medicine, Oncology, Cancer, Cancer research and Chemotherapy. The journal aims to address concerns in Internal medicine, specifically in the areas of Adverse effect, Lung cancer, Clinical trial, Colorectal cancer and Carcinoma. Targeted Oncology holds forums on Adverse effect that merges themes from other disciplines such as Gastroenterology and Surgery.
The journal dives deep in exploring the relationship between the study of Carcinoma and Retrospective cohort study. The study of Oncology encompasses disciplines such as Epidermal growth factor receptor, as well as fields such as Tyrosine-kinase inhibitor, all of which overlap with one another. While it focused on Cancer, it was also able to explore topics like Vascular endothelial growth factor, Immunology and Pathology.
Immunotherapy is a major topic of Immunology research presented in Targeted Oncology. The studies in Cancer research featured incorporate elements of Cancer cell, Tyrosine kinase, PI3K/AKT/mTOR pathway and Pharmacology. Sunitinib research presented in Targeted Oncology encompasses a variety of subjects, including Everolimus and Sorafenib.
The most cited articles are organized to reinforce research efforts on Internal medicine, Cancer, Oncology, Cancer research and Pharmacology. The studies on Cancer discussed at the most cited articles can also contribute to research in the domains of Bevacizumab, Immunology and Bioinformatics. The most cited articles mainly concentrate on Oncology but also investigate its connection with concepts in disciplines such as
The main research concerns discussed in Targeted Oncology are Internal medicine, Oncology, Adverse effect, Hazard ratio and Cancer. The in-depth study on Internal medicine also explores topics in the intersecting field of Gastroenterology. The journal explores issues in Oncology which can be linked to other research areas like Pembrolizumab, Chemotherapy, Sorafenib, Epidermal growth factor receptor and Retrospective cohort study.
In addition to Adverse effect research, it aims to explore topics under Pharmacokinetics, Neutropenia, Toxicity and Dosing. It addresses concerns in Hazard ratio which are intertwined with other disciplines, such as Renal cell carcinoma, Randomized controlled trial, Proportional hazards model and Immunotherapy. Targeted Oncology facilitates discussions on Cancer that incorporate concepts from other fields like Protein degradation, Bioinformatics, Cellular proteins, Therapeutic strategy and Reduced toxicity.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Targeted Oncology (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Targeted Oncology (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 4.35% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 37.88% were posted by at least one author from the top 10 institutions publishing in the journal. Another 12.12% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 24.24% of all publications and 25.76% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
Research is a key aspect of any role in the realm of Oncology, but it's also essential to understand the practical applications of such research in real-world clinical settings. Cancer research is a critical aspect of this field, which is constantly improving and providing innovative treatments to patients worldwide. For those looking to dive into the field of Oncology, a targeted understanding of current research topics can provide a strong foundation. But what are some career paths in Oncology that this research can translate into? Clinical roles within Oncology include roles such as oncologists, oncology nurses, radiologists and oncology pharmacists. These roles involve interacting with patients and making use of current research to interpret symptoms, diagnose conditions and monitor treatment progression. There are also roles within Oncology research. In these roles, professions are directly involved in conducting studies, analyzing data, and developing new treatment methods. This includes roles like medical scientists, biochemists, and biophysicists. Educational foundation is also a critical aspect to consider when aspiring towards a career in Oncology. Certain roles require specific nursing degrees and for that, checking some of the top nursing degrees can be beneficial. For example, a Bachelor of Science in Nursing (BSN) is a common requirement for nursing roles within Oncology. To get an idea about some of the best nursing degrees, you can check our comprehensive research about top nursing degrees in different states such as Nebraska. To know more, visit{anchor}the best nursing schools in Nebraska. With a growing demand for skilled professionals in this field, a career in Oncology promises to be fulfilling, challenging, and impactful. The vast array of roles available means that there are opportunities suited to a range of interests and skills, all contributing to the ongoing fight against cancer.
Laura Cortesi;Hope S. Rugo;Christian Jackisch
(2021)Michael A. Morse;William R. Gwin;Duane A. Mitchell
(2021)Emanuel Raschi;Milo Gatti;Francesco Gelsomino;Andrea Ardizzoni
(2020)Eric Raymond;Catherine Thieblemont;Severine Alran;Sandrine Faivre
(2020)Ying Cheng;Yong He;Wei Li;He-long Zhang
(2021)Todd M. Bauer;Alice T. Shaw;Melissa L. Johnson;Alejandro Navarro
(2020)Romain Cohen;Benoît Rousseau;Joana Vidal;Joana Vidal;Raphaël Colle
(2020)Simon Chowdhury;Anders Bjartell;Nicolaas Lumen;Pablo Maroto
(2020)Nicola Fazio;Matthew Kulke;Brad Rosbrook;Kathrine Fernandez
(2021)For those interested in the medical field but seeking alternative routes, several online degrees offer promising career pathways. Nursing, for instance, is a popular choice. Many aspiring nurses explore nursing schools with high acceptance rates, making entry into the profession more accessible without sacrificing quality education.
For graduates aiming to transition into leadership roles within healthcare, pursuing a degree in healthcare administration can be a strategic move. Online programs provide flexible options, with some of the best programs highlighted in healthcare management degree online, allowing professionals to advance their skills while balancing work commitments.
Cost is often a significant consideration for students. Fortunately, various affordable options are available if you search for health administration degree programs that fit your budget, making it easier to invest in your future without excessive financial strain.
Lastly, becoming a nurse practitioner through online studies is another effective way to deepen clinical expertise and enhance career prospects. You can explore top-tier online nurse practitioner programs that combine affordability with quality education, paving the way for advanced practice roles.
